Metformin Hydrochloride Extended-Release Tablets USP, 750 mg 100 Tablets Rx Only Manufactured by: Beximco Pharmaceuticals, LTD. 126, Kathaldia, Tongi, Gazipur, 1711, Bangladesh NDC 76385-129-01
Published September 2, 2020 · Recall initiated: August 19, 2020
Summary
FDA records drug Class II recall D-1544-2020, published September 2, 2020 and initiated August 19, 2020. Recalling firm: BAYSHORE PHARMACEUTICALS; Status: Terminated; Reported quantity: 3984 bottles; Lot: Lot #18657, Exp. 05/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations
What to do
Voluntary: Firm initiated · Letter
Get an email if METFORMIN HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- METFORMIN HYDROCHLORIDE
- Manufacturer
- BAYSHORE PHARMACEUTICALS
- Distributor
- nationwide
- Lot
- Lot #18657, Exp. 05/2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMetformin Hydrochloride Extended-Release Tablets 1000mg, 90-count bottle. Manufactured by: GlenmarkApril 16, 2025
- FDAMETFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MG, 180 TABLETS, Packaged BY: A-S Medication Solutions,April 2, 2025
- FDAMetformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 count HDPE bottles NDC# 72578-036-01February 2, 2022
- FDAMetformin HCl Extended-Release Tablets, USP, 500 mg, packaged in 500-count bottles, Rx only, Distributed by:May 19, 2021
- FDAMetformin Hydrochloride Extended-Release Tablets USP, 500 mg 1000 Tablets Rx Only Manufactured by: BeximcoSeptember 2, 2020
- FDALosartan Potassium Tablets USP, 50 mg, 90 count bottles, Rx only, Manufactured for: Camber Pharmaceuticals,September 2, 2020
Questions about this recall
Was Metformin Hydrochloride Extended-Release Tablets USP, 750 mg 100 Tablets Rx Only Manufactured by: Beximco Pharmaceuticals, LTD. 126, Kathaldia, Tongi, Gazipur, 1711, Bangladesh NDC 76385-129-01 recalled?
Yes. FDA published recall D-1544-2020 on September 2, 2020. Reported hazard: CGMP Deviations
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: METFORMIN HYDROCHLORIDE.